Alterations in Serum Adropin, Adiponectin, and Proinflammatory Cytokine Levels in OSAS
Open Access
- 6 May 2020
- journal article
- research article
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2020, 1-7
Abstract
Objective. The present study was planned to examine the relationships between obstructive sleep apnea syndrome (OSAS) and the newly revealed adipokines adropin and adiponectin concentrations that display significant metabolic and cardiovascular functions and the levels of proinflammatory cytokine levels. Method. A total of 166 overweight and obese male patients with a body mass index (BMI) >27 kg/m2 were included in the study. Among study participants, 84 were recently diagnosed with OSAS by polysomnography with an apnea-hypopnea index (AHI) ≥5, and 82 were nonapneic with normal polysomnography (AHI<5) findings. The serum adropin and adiponectin levels of all cases were analyzed via the enzyme-linked immunosorbent assay method. Serum interleukin-1 (IL-1) beta and tumor necrotizing factor-alpha (TNF-alpha) levels were determined using Luminex cytokine multiplex analyses. Results. The mean age of the OSAS patients was 50.9 ± 5.7 years and BMI was 32.4 ± 6.0 kg/m2, and there was no statistically significant difference determined with the control group (49.3 ± 5.8 years and 30.6 ± 5, 6 kg/m2) (). There were no statistically significant differences between the OSAS and control groups concerning total cholesterol, triglyceride, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and glucose levels. Adiponectin was lower in the OSAS group at a statistically significant level in comparison with the control group and was related at a statistically significant level to OSAS intensity. Adropin concentration was determined to be higher in the OSAS group at a statistically significant level in comparison with the control group. Conclusion. The results of our study suggest that increased adropin concentration may be an indicator of endothelium dysfunction in OSAS patients. Serum adropin and adiponectin levels may be new bioindicators used for diagnosis and risk assessment in OSAS patients.
Keywords
This publication has 26 references indexed in Scilit:
- Influence of pharyngeal muscle activity on inspiratory negative effort dependence in the human upper airwayRespiratory Physiology & Neurobiology, 2014
- Influence of CPAP treatment on airway and systemic inflammation in OSAS patientsSleep and Breathing, 2012
- The Association of Obesity with Insulin Resistance in Male Patients with Obstructive Sleep Apnea Syndrome in KoreaPsychiatry Investigation, 2011
- Frequency of distribution of inflammatory cytokines IL-1, IL-6 and TNF-alpha gene polymorphism in patients with obstructive sleep apnea.2008
- Comparison of Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels between Patients with and without Obstructive Sleep Apnea SyndromeRespiration, 2008
- Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndromeAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Serum Levels of Adipocytokines, Adiponectin and Leptin, in Patients with Obstructive Sleep Apnea SyndromeInternal Medicine, 2008
- Reduced levels of adiponectin in sleep apnea syndromeJournal of Endocrinological Investigation, 2006
- The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndromeCytokine, 2004
- Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, AdiponectinThe Journal of Clinical Endocrinology & Metabolism, 2001